Abstract
Numerous articles reported that dysregulated expression levels of miRNAs correlated with survival time of HCC patients. However, there has not been a comprehensive meta-analysis to evaluate the accurate prognostic value of miRNAs in HCC. Meta-analysis. Studies, published in English, estimating expression levels of miRNAs with any survival curves in HCC were identified up until 15 April, 2017 by performing online searches in PubMed, EMBASE, Web of Science and Cochrane Database of Systematic Reviews by two independent authors. The pooled hazard ratios (HR) with 95% confidence intervals (CI) were used to estimate the correlation between miRNA expression and overall survival (OS). 54 relevant articles about 16 miRNAs, with 6464 patients, were ultimately included. HCC patients with high expression of tissue miR-9 (HR = 2.35, 95% CI = 1.46-3.76), miR-21 (HR = 1.76, 95% CI = 1.29-2.41), miR-34c (HR = 1.64, 95% CI = 1.05-2.57), miR-155 (HR = 2.84, 95% CI = 1.46-5.51), miR-221 (HR = 1.76, 95% CI = 1.02-3.04) or low expression of tissue miR-22 (HR = 2.29, 95% CI = 1.63-3.21), miR-29c (HR = 1.35, 95% CI = 1.10-1.65), miR-34a (HR = 1.84, 95% CI = 1.30-2.59), miR-199a (HR = 2.78, 95% CI = 1.89-4.08), miR-200a (HR = 2.64, 95% CI = 1.86-3.77)...Continue Reading
References
Jun 9, 2007·Trials·Jayne F TierneyMatthew R Sydes
Jul 24, 2008·International Journal of Cancer. Journal International Du Cancer·Wenxi LiJianren Gu
Jul 30, 2008·Proceedings of the National Academy of Sciences of the United States of America·Patrick S MitchellMuneesh Tewari
Sep 4, 2008·Cell Research·Xi ChenChen-Yu Zhang
Aug 13, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Laura GramantieriMassimo Negrini
Jan 28, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Queenie W-L WongNathalie Wong
Aug 24, 2010·Oncogene·K-F ChenA-L Cheng
Sep 16, 2010·British Journal of Cancer·J ZhangW Zhou
Oct 19, 2010·Gastroenterology·Carmen Chak-Lui WongIrene Oi-Lin Ng
Oct 28, 2010·British Journal of Cancer·Y TomimaruM Mori
Feb 8, 2011·Biochemical and Biophysical Research Communications·Jipeng LiJianping Luo
Apr 5, 2011·Human Pathology·Sun Och YoonEunsil Yu
May 12, 2011·Journal of Gastroenterology and Hepatology·Chuanxi WangJunqing Han
Jun 16, 2011·Gut·Fang ZhengDan Xie
Jul 14, 2011·Journal of Hepatology·Yoshito TomimaruMasaki Mori
Jul 26, 2011·Medical Oncology·Hong-Yuan ChenZhi-Hai Peng
Sep 1, 2011·The Journal of Biological Chemistry·Dong LiXuetao Cao
Sep 6, 2011·Journal of Hepatology·Shupeng LiuShanrong Liu
Oct 5, 2011·Neoplasia : an International Journal for Oncology Research·Yinghua HeXiaoying Luo
Nov 11, 2011·Journal of Cancer Research and Clinical Oncology·Zhong-Bo HanZhi-Hai Peng
Dec 3, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Chun-Ming WongIrene Oi-Lin Ng
Jan 4, 2012·Molecular Carcinogenesis·Andreas KarakatsanisDionysios Voros
Feb 23, 2012·Lancet·Alejandro FornerJordi Bruix
Mar 21, 2012·Carcinogenesis·Priscilla T-Y LawNathalie Wong
Mar 28, 2012·FEBS Letters·Na HuangRongcheng Luo
Apr 25, 2012·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Qing-jun LiKe-feng Dou
May 16, 2012·Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research·Ling ChenHuihuan Tang
May 26, 2012·PloS One·Ya-Hui HuangChau-Ting Yeh
Jun 12, 2012·BMC Cancer·Jian WangXinwei Zhang
Jul 7, 2012·PloS One·Qian BiDaiming Fan
Oct 20, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Silvia Giordano, Amedeo Columbano
Nov 28, 2012·FEBS Letters·Yanqiong ZhangNa Lin
Jan 4, 2013·PloS One·Hai-Tao ZhuLun-Xiu Qin
Jan 8, 2013·Molecular and Cellular Biochemistry·Hao GuJinhui Zhang
Jan 17, 2013·BMC Cancer·Minhua RongYiwu Dang
Feb 5, 2013·Journal of Hepatology·Priscilla T-Y LawNathalie Wong
Feb 5, 2013·Clinical & Experimental Metastasis·Hongyuan ChenZhihai Peng
Feb 8, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Xin YangLun-Xiu Qin
Feb 13, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hao YangLianyue Yang
Mar 8, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ruizhi WangShi-Mei Zhuang
Mar 19, 2013·BMC Cancer·Yoshiki MurakamiMasahiko Kuroda
Apr 19, 2013·Journal of Experimental & Clinical Cancer Research : CR·Ming-Qi FanLin Zhong
Apr 30, 2013·Cell·Luke A YatesRobert J C Gilbert
May 8, 2013·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Qiaoming ZhiYuting Kuang
Jun 4, 2013·Oncogene·H J BaeS W Nam
Jun 4, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Wen-Ping XuWei-Fen Xie
Jun 15, 2013·The Journal of International Medical Research·Lin ZhouYangde Zhang
Jul 3, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Verena KöberleOliver Waidmann
Jul 12, 2013·Molecular and Cellular Biochemistry·Ping ChenLiang Ma
Jul 19, 2013·Technology in Cancer Research & Treatment·Fan YangKe-feng Dou
Citations
Jun 21, 2019·MicroRNA·Ioannis A ZiogasGeorgios Tsoulfas
Aug 10, 2018·Yonsei Medical Journal·Xiu Qing LinWei Wu
Sep 26, 2019·Biology Open·Yiqing ZhuFang Wang
Mar 9, 2019·Current Drug Targets·Seyed Mostafa ParizadehAmir Avan
Aug 28, 2018·BioMed Research International·Huaixiang ZhouLiu Yang
Jan 6, 2019·Archives of Pharmacal Research·Mi Jeong HeoSang Geon Kim
Feb 13, 2021·Molecular Genetics and Genomics : MGG·Zhendong LiuXingyong Shen
Jun 29, 2021·Seminars in Cancer Biology·Showket HussainShafiul Haque
Aug 7, 2021·Biochemistry and Biophysics Reports·Ashraf A DawoodMona S Habieb
Aug 10, 2021·Frontiers in Cell and Developmental Biology·Duoduo LvHong Tang
Apr 16, 2019·Oncology Research·Chao JiangGuangyi Wang